Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 3Recurrence 2Pleural Effusion, Malignant 2Mesothelioma, Malignant 2Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1NSCLC 1Myeloproliferative Disorders 1Multiple Myeloma 1Melanoma 1Lymphoma 1Lymphedema 1Leukemia, Myeloid, Chronic-Phase 1Immunoglobulin Light-chain Amyloidosis 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1Glioblastoma 1Fibrosis 1Fallopian Tube Neoplasms 1Dysplastic Nevus Syndrome 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Music Therapy 7Cognitive Behavioral Therapy 6Surveys and Questionnaires 4Standard of Care 4Saline Solution 4Hypnosis 4Esketamine 4Therapeutics 3Psilocybin 3Palliative Care 2Methods 2Cannabidiol 2Art Therapy 2nabiximols 1Waiting Lists 1Videotape Recording 1Transcutaneous Electric Nerve Stimulation 1Transcranial Direct Current Stimulation 1Timbre Perception 1Sertraline 1Self-Help Groups 1Selective Serotonin Reuptake Inhibitors 1Respiration 1Relaxation Therapy 1Referral and Consultation 1Psychotherapy 1Psychosocial Intervention 1Psychiatric Rehabilitation 1Population Groups 1Pharmaceutical Preparations 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anxiety Disorders × Pharmaceutical Preparations × 1 year × Clear all
NCT07174947 2026-03-24

SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety

First Affiliated Hospital of Wenzhou Medical University

Phase 2 Recruiting
240 enrolled

Anxiety Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡